A citation-based method for searching scientific literature

D Giugliano, M I Maiorino, G Bellastella, K Esposito. J Endocrinol Invest 2019
Times Cited: 28







List of co-cited articles
113 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 Diabetes.
Olga Montvida, Jonathan Shaw, John J Atherton, Frances Stringer, Sanjoy K Paul. Diabetes Care 2018
130
17

Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013.
Kasia J Lipska, Xiaoxi Yao, Jeph Herrin, Rozalina G McCoy, Joseph S Ross, Michael A Steinman, Silvio E Inzucchi, Thomas M Gill, Harlan M Krumholz, Nilay D Shah. Diabetes Care 2017
177
17

Clinical inertia and its impact on treatment intensification in people with type 2 diabetes mellitus.
G Reach, V Pechtner, R Gentilella, A Corcos, A Ceriello. Diabetes Metab 2017
102
17

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
17


Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Maria Ida Maiorino, Paolo Chiodini, Giuseppe Bellastella, Annalisa Capuano, Katherine Esposito, Dario Giugliano. Diabetes Care 2017
62
14

The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials.
Maria Ida Maiorino, Paolo Chiodini, Giuseppe Bellastella, Lorenzo Scappaticcio, Miriam Longo, Dario Giugliano, Katherine Esposito. Diabetes Res Clin Pract 2019
9
44

Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people.
Kamlesh Khunti, Michael L Wolden, Brian Larsen Thorsted, Marc Andersen, Melanie J Davies. Diabetes Care 2013
385
14

Clinical inertia-Time to reappraise the terminology?
Kamlesh Khunti, Melanie J Davies. Prim Care Diabetes 2017
46
14

Achievement of Glycated Hemoglobin Goals in the US Remains Unchanged Through 2014.
Ginger Carls, Johnny Huynh, Edward Tuttle, John Yee, Steven V Edelman. Diabetes Ther 2017
121
14




Clinical inertia as a clinical safeguard.
Dario Giugliano, Katherine Esposito. JAMA 2011
58
10

Efficacy and Safety of IDegLira Versus Basal-Bolus Insulin Therapy in Patients With Type 2 Diabetes Uncontrolled on Metformin and Basal Insulin: The DUAL VII Randomized Clinical Trial.
Liana K Billings, Ankur Doshi, Didier Gouet, Alejandra Oviedo, Helena W Rodbard, Nikolaos Tentolouris, Randi Grøn, Natalie Halladin, Esteban Jodar. Diabetes Care 2018
80
10

Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.
K Khunti, A Nikolajsen, B L Thorsted, M Andersen, M J Davies, S K Paul. Diabetes Obes Metab 2016
160
10

Addressing Clinical Inertia in Type 2 Diabetes Mellitus: A Review.
Jennifer Okemah, John Peng, Manuel Quiñones. Adv Ther 2018
65
10

DOES CLINICAL INERTIA VARY BY PERSONALIZED A1C GOAL? A STUDY OF PREDICTORS AND PREVALENCE OF CLINICAL INERTIA IN A U.S. MANAGED-CARE SETTING.
Jay Lin, Steve Zhou, Wenhui Wei, Chunshen Pan, Melissa Lingohr-Smith, Philip Levin. Endocr Pract 2016
28
10

Clinical inertia.
L S Phillips, W T Branch, C B Cook, J P Doyle, I M El-Kebbi, D L Gallina, C D Miller, D C Ziemer, C S Barnes. Ann Intern Med 2001
994
10

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
10

Clinical inertia in individualising care for diabetes: is there time to do more in type 2 diabetes?
William David Strain, Matthias Blüher, Païvi Paldánius. Diabetes Ther 2014
44
10


Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem.
William H Polonsky, Lawrence Fisher, Susan Guzman, Leonel Villa-Caballero, Steven V Edelman. Diabetes Care 2005
374
10

Deintensification in older patients with type 2 diabetes: A systematic review of approaches, rates and outcomes.
Samuel Seidu, Setor K Kunutsor, Pinar Topsever, Clare E Hambling, Francesc X Cos, Kamlesh Khunti. Diabetes Obes Metab 2019
19
15

Clinical inertia versus overtreatment in glycaemic management.
Kamlesh Khunti, Melanie J Davies. Lancet Diabetes Endocrinol 2018
17
17

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
10

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
10

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
10

Potential overtreatment of diabetes mellitus in older adults with tight glycemic control.
Kasia J Lipska, Joseph S Ross, Yinghui Miao, Nilay D Shah, Sei J Lee, Michael A Steinman. JAMA Intern Med 2015
233
10



Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
10

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
10

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Mansoor Husain, Andreas L Birkenfeld, Morten Donsmark, Kathleen Dungan, Freddy G Eliaschewitz, Denise R Franco, Ole K Jeppesen, Ildiko Lingvay, Ofri Mosenzon, Sue D Pedersen,[...]. N Engl J Med 2019
510
10

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Hertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, Rafael Diaz, Mark Lakshmanan, Prem Pais, Jeffrey Probstfield, Jeffrey S Riesmeyer, Matthew C Riddle, Lars Rydén,[...]. Lancet 2019
828
10


Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics.
Margaret A Powers, Joan Bardsley, Marjorie Cypress, Paulina Duker, Martha M Funnell, Amy Hess Fischl, Melinda D Maryniuk, Linda Siminerio, Eva Vivian. Clin Diabetes 2016
109
10

Beyond basal-bolus insulin regimen: Is it still the ultimate chance for therapy in diabetes?
Dario Giugliano, Giuseppe Bellastella, Maria Ida Maiorino, Katherine Esposito. Diabetes Res Clin Pract 2019
4
75

Heart failure and type 2 diabetes: From cardiovascular outcome trials, with hope.
Dario Giugliano, Juris J Meier, Katherine Esposito. Diabetes Obes Metab 2019
31
7

Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control.
Steven V Edelman, William H Polonsky. Diabetes Care 2017
145
7


Standardizing terminology and definitions of medication adherence and persistence in research employing electronic databases.
Marsha A Raebel, Julie Schmittdiel, Andrew J Karter, Jennifer L Konieczny, John F Steiner. Med Care 2013
271
7

A Real-World Observational Study of Time to Treatment Intensification Among Elderly Patients with Inadequately Controlled Type 2 Diabetes Mellitus.
Mayank Ajmera, Amit Raval, Steve Zhou, Wenhui Wei, Rituparna Bhattacharya, Chunshen Pan, Usha Sambamoorthi. J Manag Care Spec Pharm 2015
14
14

Resurgence in Diabetes-Related Complications.
Edward W Gregg, Israel Hora, Stephen R Benoit. JAMA 2019
105
7

Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review.
Kamlesh Khunti, Marilia B Gomes, Stuart Pocock, Marina V Shestakova, Stéphane Pintat, Peter Fenici, Niklas Hammar, Jesús Medina. Diabetes Obes Metab 2018
131
7

Transition to insulin in Type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers.
Sasson Nakar, Gila Yitzhaki, Reena Rosenberg, Shlomo Vinker. J Diabetes Complications 2007
108
7


Identification of barriers to insulin therapy and approaches to overcoming them.
David Russell-Jones, Frans Pouwer, Kamlesh Khunti. Diabetes Obes Metab 2018
104
7

Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes.
Sanjoy K Paul, Kerenaftali Klein, Brian L Thorsted, Michael L Wolden, Kamlesh Khunti. Cardiovasc Diabetol 2015
139
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.